ESR1 and cancer: Previous research (Migliaccio et al. 2006; Vivacqua et al. 2009) showed that EGFR co-immunoprecipitates with ERα and GPER, suggesting that an intricate crosstalk may occur among these main transduction mediators in cancer cells.